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Abstract
Obstructive sleep apnea (OSA) occurs in at least 10% of the population, and leads to higher morbidity and mortality;
however, relationships between OSA severity and sleep or psychological symptoms are unclear. Existing studies include
samples with wide-ranging comorbidities, so we assessed relationships between severity of OSA and common sleep and
psychological disturbances in recently diagnosed OSA patients with minimal co-morbidities. We studied 49 newly
diagnosed, untreated OSA patients without major co-morbidities such as mental illness, cardiovascular disease, or stroke;
subjects were not using psychoactive medications or tobacco (mean 6 std age: 46.869.1 years; apnea/hyponea index [AHI]:
32.1620.5 events/hour; female/male: 12/37; weight ,125 kg). We evaluated relationships between the AHI and daytime
sleepiness (Epworth Sleepiness Scale; ESS), sleep quality (Pittsburg Sleep Quality Index; PSQI), depressive symptoms (Beck
Depression Inventory-II; BDI), and anxiety symptoms (Beck Anxiety Inventory; BAI), as well as sex and body mass index (BMI).
AHI was similar in females and males. Mean levels of all symptoms were above normal thresholds, but AHI was not
correlated with age, ESS, PSQI, BDI, or BAI; only BMI was correlated with OSA severity. No differences in mean AHI appeared
when subjects were grouped by normal versus elevated values of ESS, PSQI, BDI, or BAI. Consistent with other studies, a
strong link between OSA severity and psychological symptoms did not appear in these newly diagnosed patients,
suggesting that mechanisms additional to the number and frequency of hypoxic events and arousals occurring with apneas
contribute to adverse health effects in OSA. OSA patients presenting with mild or moderate severity, and no major co-
morbidities will not necessarily have low levels of sleep or psychological disturbances.
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Introduction
Obstructive sleep apnea (OSA) occurs in approximately 10% of
the population, leads to physical and psychological co-morbidities,
and is associated with higher all-cause mortality [1,2,3,4].
Symptoms of OSA include daytime sleepiness, poor sleep quality,
and co-morbidities such as high levels of depressive symptoms and
anxiety [5,6,7], but the relationship between OSA severity and
accompanying symptoms is weak. The severity of OSA, as defined
by the American Academy of Sleep Medicine [4], is classified by
the number of partial or complete cessations of breathing per hour
during sleep, the apnea/hypopnea index (AHI). However, most
studies do not report strong relationships between AHI and
severity of symptoms [8,9]. The extent to which a patient’s
reported AHI level predicts severity of symptoms remains unclear,
and is the topic of recent investigations [10,11,12,13].
Excessive daytime sleepiness is the most common symptom
associated with OSA [4,6]. High daytime sleepiness is often a
primary reason for referring a person for a polysomnographic
study, and the evidence of higher measures of daytime sleepiness
in OSA is unequivocal [4,6]. Since OSA is defined according to a
cut-off in AHI, a logical assumption is that higher AHI leads to
higher daytime sleepiness. However, while some large samples
show a statistically significant correlation, AHI and daytime
sleepiness measures are not strongly correlated [9,13,14,15,16,17],
a pattern noted in the revised International Classifications of Sleep
Disorders criteria [18].
Other symptoms that are present in persons with OSA also
show only weak relationships with AHI. Poor sleep quality is
common in people with OSA, but is not explained by AHI [19],
even though obstructive events are typically associated with
arousals. Apneic indices fail to explain other characteristics: levels
of depressive symptoms, while high in approximately half of OSA
patients [5,20,21,22], correlate at best poorly with AHI [10,23],
and similar findings are true for anxiety symptoms [24,25,26].
Mood and affect disturbances could arise from neural injury that
occurs in the condition [27,28,29,30], and such injury would be
expected to be greater with increasing severity, since animal
evidence shows that repeated hypoxic episodes lead to cellular
injury and death in a dose-dependent fashion [31,32,33,34].
Existing studies mostly describe typical OSA populations that
include patients with major risk factors for illness and co-morbidities,
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cardiovascular disease. Since these factors influence sleep and
affective symptoms, it is possible that a stronger relationship
between OSA severity and symptoms will be present in a sample of
patients without major health issues other than OSA. Therefore,
our objective was to describe relationships between severity of OSA
and severity of common sleep and psychological disturbances
present in the sleep disorder, in a sample with minimal co-
morbidities. We studied recently-diagnosed, moderate to severe
OSA patients with minimal comorbidities, who had not started
treatment, and who did not have other major cardiovascular or
psychiatric disorders.
Methods
All procedures were approved by the UCLA Institutional
Review Board, and all participants provided written, informed
consent.
We performed a cross-sectional study of OSA patients, diagnosed
based on an overnight sleep study, who completed commonly-used
questionnaires for evaluation of sleep and psychological symptoms.
Subjects
We studied 49 newly diagnosed, untreated OSA patients
without major comorbidities (Table 1). Subjects were recruited
via the UCLA Sleep Disorders Laboratory. Patients were
untreated for the sleep disorder, did not currently smoke, and
were not taking psychiatric medications. Screening was by self-
report on initial clinical interview prior to study onset. These
subjects were originally recruited as part of a brain imaging study
[28], so inclusion criteria due to scanner limitations included a
weight of less than 125 kg, no claustrophobia, and absence of
metallic implants.
Data Collection
The OSA severity was determined based on an overnight sleep
study. The AHI, or number of apnea/hypopnea per hour, was
determined according to standard criteria [4].
We collected subject characteristics of age, sex and body mass
index (BMI), as well as measures of sleep, depression and anxiety
symptoms. All symptoms were assessed with commonly-used self-
report questionnaires. Daytime sleepiness was measured with the
Epworth Sleepiness Scale (ESS), sleep quality by the Pittsburgh
Sleep Quality Index (PSQI), depressive symptoms with the Beck
Depression Inventory II (BDI), and anxiety symptoms with the
Beck Anxiety Inventory (BAI). These measures show moderate to
strong validity and reliability in healthy people and in groups with
medical conditions [35,36,37,38,39], although OSA populations
have not been assessed.
Statistical analysis
The non-parametric Spearman’s rho was calculated for AHI
correlations with ESS, PSQI, BDI, BAI and BMI. Mean AHI
values were compared between groups that were defined by
classifying subjects into normal and elevated symptom levels, using
independent samples t-tests. The standard p threshold of 0.05 was
used. The 95% confidence intervals for Spearman’s rho were
calculated using a bootstrap method (500 samples). Correlations
and independent samples t-tests were performed with the statistical
software SPSS (Chicago, IL), and the confidence intervals were
calculated with the bootstrap function in MATLAB 7.8 with the
Statistics Toolbox (The Mathworks Inc., Natwick, MA). Power
analyses were performed with G*Power 3 [40].
Table 1. Subject information.
Characteristics
Sex 12 R:3 7=
Mean St Dev Range
Age (years) 46.8 ±9.1 31–63
BMI (kg/m
2) 30.4 ±5.1 21–43
Years Education* (N=11) 19 ±3 16–25
Sleep
AHI (events/hour) 32.1 ±20.5 5–101
SaO2 nadir{ 80.2 ±9.4 50–96
SaO2 baseline{ 94.9 ±1.9 88–97
Apnea type{ N%
Positional (supine) 8 17%
REM-only 11 23%
All-stage (non-specific) 29 60%
Symptoms
ESS 10.5 ±4.9 0–24
PSQI 9.3 ±4.2 0–20
BDI 9.7 ±8.8 0–37
BAI 11.2 ±12.1 0–54
Medical History N%
Cardioascular disease (angina, atherosclerosis,
cerebrovascular disease, coronary artery
disease, heart failure, myocardial infarction)
00 %
Diabetes 5 10%
Gout 24 %
Hypertension 17 35%
Diagnosed Mental Health Disorder 00 %
Migraines 00 %
Sleep disorder (not OSA) 00 %
Stroke 00 %
Tobacco (past use) 8 16%
Vascular congenital abnormality 00 %
Medications
Anti-depressant (past use) 36 %
Anti-anxiety (past use) 12 %
Statin{ 9 19%
ACE/ARB{ 6 13%
Characteristics and symptoms of 49 OSA patients; BMI = body mass index; AHI
= apnea/hypopnea index (severity of OSA); SaO2 = blood oxygen saturation
(oximetry); REM = rapid eye movement sleep; ESS = Epworth Sleepiness Scale;
PSQI = Pittsburgh Sleep Quality Index; BDI = Beck Depression Inventory II; BAI
= Beck Anxiety Inventory; ACE = angiotensin-converting enzyme inhibitor;
ARB = angiotensin receptor blocker; statin = cholesterol-lowering via
inhibition of HMG-CoA reductase enzyme.
*Missing data for N = 38 subjects; years of education were not originally
collected.
{Missing data points (indicates that one subject’s value is missing, but not
always the same subject); one subject missing for each of SaO2 and position
measurements due to technical failures, blood pressure medication history not
collected for one subject; summary values are shown for the remaining 48
subjects.
doi:10.1371/journal.pone.0010211.t001
OSA Severity and Symptoms
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Main Findings
The AHI, the ‘‘gold standard’’ of obstructive sleep apnea
severity, was not significantly correlated with symptoms of daytime
sleepiness, sleep quality, depression, or anxiety. Specifically, AHI
showed no significant correlations with age, ESS, PSQI, BDI, or
BAI (Table 2, 1
st column). Only BMI showed a significant positive
correlation with AHI. Additionally, we found no group differences
in mean AHI when subjects were categorized into two groups
according to normal/elevated measures of each of ESS, PSQI,
BDI, or BAI (Table 3). We used a cutoff of .9 to classify BDI
measures as high, a threshold lower than the typical 14, but a more
sensitive level [41], which we previously showed can predict
additional neural injury in high relative to low BDI OSA patients
[42]. The full correlation table showed additional significant
relationships between all combinations of BDI, BAI and PSQI
(Table 2).
Power Analysis
A medium-to-large effect size, measured as Pearson’s r, of 0.38
(0.34 one-tailed) would be required to detect any relationship with
80% power at a=0.05 [40]. The largest symptom and AHI
correlation effect size (non-parametric equivalent) found in this
sample was 0.18 (Table 2, 1
st column).
Discussion
A strong link between the standard measure of OSA severity, the
AHI, and accompanying symptoms did not appear in these newly-
diagnosed patients, who were untreated and without major co-
morbid illness. However, the presence of OSA, diagnosed primarily
based on AHI values, was associated with abnormally high levels of
depressive and anxious symptoms, daytime sleepiness, and poor
sleep quality.Thesefindingssuggestthatmechanismsotherthanthe
number and frequency of hypoxic events contribute to adverse
health effects in this patient population.
As found in other OSA populations [11,43], levels of daytime
sleepiness, poor sleep quality, depression and anxiety were high,
with mean levels of these symptoms above normal cutoff thresholds
(Table 3). Thus, the absence of correlation between symptoms and
disease severity does not result from low levels of symptoms in this
set of OSA patients. One possibility is that the population consists of
several distinct subgroups, which are affected differently by the
apneic periods. Variations in affective and mood symptoms in
particular are likely to be associated with variations in a number of
symptoms related to neural functioning, as we previously showed
that,insubsetsofthepresent49OSApatients,depressive symptoms
are associated with brain structural changes, as are symptoms of
anxiety [42,44]. Our neuroimaging findings show differential effects
onbrainstructureofdiabetes,sleepstateinwhichapneasoccur,and
sex [45,46,47]. The heterogeneous nature of characteristics
associated with brain changes in OSA suggests that these variables
should be considered separately with regards to their influence on
sleep and psychological symptoms; the present study did not have
enough subjects to power such tests.
The findings support the hypothesis that AHI is not the most
appropriate polysomnographic measure of clinical impact of OSA,
a relationship noted previously [48,49]. One possible reason is that
Table 2. Correlations.
Correlation table
AHI Age BMI ESS PSQI BDI
Characteristics
Age r 20.06
p 0.67
CI [20.33, 0.28]
BMI r 0.33 * 0.07
p 0.002 0.63
CI [0.00, 0.57] [20.29, 0.37]
Symptoms
ESS r 20.18 20.16 0.04
p 0.21 0.28 0.80
CI [20.47, 0.36] [20.47, 0.11] [20.26, 0.40]
PSQI r 0.07 20.20 0.12 0.08
p 0.61 0.16 0.40 0.56
CI [20.21, 0.36] [20.48, 0.07] [20.16, 0.41] [20.23, 0.34]
BDI r 0.03 20.18 0.13 0.20 0.74 *
p 0.83 0.23 0.36 0.16 ,0.001
CI [20.25, 0.34] [20.49, 0.15] [20.16, 0.42] [20.06, 0.50] [20.57, 0.85]
BAI r 0.09 0.02 0.21 0.24 0.47 * 0.72 *
p 0.55 0.91 0.14 0.09 ,0.001 ,0.001
CI [20.17, 0.38] [20.28, 0.33] [20.08, 0.48] [20.04, 0.44] [20.22, 0.67] [20.54, 0.82]
Correlation table of subject characteristics, symptoms, and OSA severity; Spearman’s rho, p value, and 95% confidence interval (CI) are shown for each correlation (*
indicates significant). BMI = body mass index; AHI = apnea/hypopnea index (severity of OSA); ESS = Epworth Sleepiness Scale; PSQI = Pittsburgh Sleep Quality Index;
BDI = Beck Depression Inventory II; BAI = Beck Anxiety Inventory.
doi:10.1371/journal.pone.0010211.t002
OSA Severity and Symptoms
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severity of apneic events. Symptoms like poor sleep quality and
daytime sleepiness may be more closely related to number and
extent of arousals, which are principally associated with obstruc-
tive apneas. The frequency of arousals is a better predictor of
fatigue [8], another common symptom of OSA [50]. Similarly,
blood oxygen desaturation appears to be a better predictor than
AHI of daytime sleepiness [51] and cardiovascular sequelae
[52,53]. The problem of defining clinically-relevant operational
definitions of sleep variables was part of the motivation for the
development by the American Academy of Sleep Medicine of new
scoring criteria in 2007 [54], although it is unclear whether the
new definitions of severity are better predictors of symptoms.
The lack of strong correlations between AHI and subjective
sleep symptoms suggests that factors other than respiratory events
and arousal contribute to these disturbances. Affective disruptions
appear to be closely related to sleep quality: the PSQI had the
strongest correlations with the BDI and BAI, similar to a previous
report [25]. While self-reports are potentially inaccurate, especially
in psychologically disturbed populations, the PSQI has moderate
to high validity and reliability [35], with validation in other sleep-
disturbed populations [55].
Determining the extent to which mood disruptions are
independent of OSA is problematic, since several mental illnesses,
including depression, are classified by symptoms that include sleep
disturbances [56]. The BDI includes questions on symptoms that
overlap typical OSA characteristics, such as sleepiness and fatigue,
loss of libido, and impaired concentration. This overlap does not
alter the depressive symptoms themselves but confounds interpre-
tationofthesource ofthemood disturbances;wecannotdisentangle
the extent to which individuals with depressed mood experience a
disorder independent of OSA. The DSM-IV criteria for organic
rule-out of a primary mood disorder, i.e., diagnosis of a mood
disorder that is secondary to a physical medical illness [57], do not
clarify whether depressed mood in OSA should be considered
secondary to the physical disorder. Our earlier work demonstrating
that mildly depressed or anxious OSA subjects show greater brain
injury over patients with normal mood or affect suggests a neural
basis for the mood disturbances [42,44]. However, whether OSA
preceded the neural injury and mood symptoms cannot be
determined in the present cross-sectional study.
Limitations of the current study include the specific nature of
the study population; a group with minimal co-morbidities, recent
diagnosis, and limited BMI is not representative of the general
OSA population. Furthermore, the heterogenous nature of the
disorder, even within the restricted sample used here, means that a
much larger number of subjects than 49 would need to be studied
to verify that the findings generalize to a larger population.
Additional limitations relate to the lack of objective measures of
symptoms. However, the variables assessed in the present study
reflect information typically available to, or easily collected by
clinicians. More-accurate measurements may allow relationships
between OSA severity and symptoms to be detected, but given the
minimal effects found in this and other studies, it is unlikely that
any strong correlation would appear using different measures.
Other potential approaches to refining the analysis include
increasing the number of subjects, or selecting a different OSA
population. In particular, a possibility would be to study separate
populations based on depression, sex, or sleep quality, to
potentially elucidate relationships within those subgroups.
Clinical Implications
A patient’s reported OSA severity should not be assumed to
directly relate to severity of accompanying psychological symp-
toms. These findings do not negate the importance of sleep-
disordered breathing; many clinical symptoms are associated with
sleep disturbances, and screening for the presence of sleep
disorders, including OSA, is important [58]. The present results
are limited to newly-diagnosed, untreated, middle-aged OSA
patients without major co-morbid illness, and weighing less than
125 kg, so different patterns may appear in other OSA
populations. Obesity (measured as BMI), a known risk factor for
the sleep disorder, is associated with OSA severity, as is the most
prominent co-morbidity, hypertension [12,59]. For patients who
have received a sleep study, the presence of OSA of any severity
would suggest that a patient likely has abnormally high levels of
daytime sleepiness, depression, and anxiety, as well as poor sleep
quality. For patients without an assessment for OSA, but
presenting with sleepiness, depression, and complaints of poor
sleep, the presence of OSA may be suspected, but the level of
symptoms should not be assumed to relate to the severity of the
sleep disorder.
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Table 3. Mean comparisons.
AHI – Comparing means
N Mean ± std N Mean ± std Diff se P
Characteristics
Female Male = - R
Sex 12 24.3±18.8 37 34.1±19.7 9.9 6.3 0.8
Symptoms Cutoff Normal High High -Normal
PSQI .5 7 22.7±13.0 42 33.2±20.3 10.5 5.8 0.2
ESS .9 19 32.2±14.8 30 31.4±22.5 20.8 5.8 0.9
BDI .9 29 33.0±20.9 20 29.9±18.2 23.1 5.6 0.6
BAI .7 26 28.9±16.5 23 34.9±22.7 6.1 5.7 0.2
Mean AHI compared across groups of subjects classified according to symptom severity or sex, using independent samples t-tests; ESS = Epworth Sleepiness Scale;
PSQI = Pittsburgh Sleep Quality Index; BDI = Beck Depression Inventory II; BAI = Beck Anxiety Inventory.
doi:10.1371/journal.pone.0010211.t003
OSA Severity and Symptoms
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